Table 2 Accumulated overall survival (OS) rates (median, mean, 1-, 2-, and 5-year) of de novo prostate cancer patients with bone metastases
Metastatic sites | Median survival (months) | Mean survival (months) | 1-year (%) | 2-year (%) | 5-year (%) |
|---|---|---|---|---|---|
Bone-only | 27 | 35.87 | 73.6 | 53.4 | 24.2 |
Bone and lung | 20 | 30.74 | 63.2 | 44.6 | 22.1 |
Bone and liver | 10 | 17.39 | 44.5 | 22.6 | 5.1 |
Bone and brain | 10 | 19.11 | 42.0 | 23.9 | 11.8 |
Bone and ≥ 2 other sites | 11 | 20.23 | 45.5 | 26.4 | 11.4 |